Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

BACKGROUND The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor Xa inhibitor, may provide more consistent and predictable anticoagulation than warfarin. METHODS In a double-blind...

Descripción completa

Detalles Bibliográficos
Autores Principales: Patel, Manesh, Mahaffey, Kenneth, Garg, Jyotsna, Pan, Guohua, Singer, Daniel, Hacke, Werner, Breithardt, Gunter, Halperin, Jonathan, Hankey, Graeme, Piccini, Jonathan, Becker, Richard, Nessel, Christopher
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: Massachusetts Medical Society 2011
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/26913
https://doi.org/10.1056/NEJMoa1009638